Evidence map›Paper›PMID 21426455›Full record

ArticlePediatric diabetes2011

Onset features and subsequent clinical evolution of childhood diabetes over several years.

Rebecca B Lipton, Melinda L Drum, Kirstie K Danielson, Siri Aw Greeley, Graeme I Bell, William A Hagopian

Abstract readMulticenter Study
In one paragraph

Article in Pediatric diabetes, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rebecca B LiptonBiological Sciences Division, University of Chicago, Chicago, IL, USA. lipton@uchicago.edu
Melinda L Drum
Kirstie K Danielson
Siri Aw Greeley
Graeme I Bell
William A Hagopian
University of Chicago · USPacific Northwest Diabetes Research Institute · US

Funding

TRANSGENIC COREP60DK020595 · NIDDK · UNIVERSITY OF CHICAGO · PI BELL, GRAEME I · 1985 to 2012
$25.5M
TRANSLATIONAL RESEARCH UNIVERSITY OF CHICAGO: CLINICAL TRIALSUL1RR024999 · NCRR · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2007 to 2011
$25.3M
ZOLEDRONATE &OSTEOPOROTIC EFFECTS OF ANDROGEN DEPRIVATIM01RR000055 · NCRR · UNIVERSITY OF CHICAGO · PI DE WIT, HARRIET · 1985 to 2007
$19.0M
WOMEN'S INTERAGENCY HIV STUDY (WIHS) ANTIRETROVIRAL TREATMENT EXPOSURE/INTENSIVEM01RR013987 · NCRR · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BUTTRICK, PETER · 2000 to 2004
$9.2M
MINORITY TYPE 1 DIABETES REGISTRYR01DK044752 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI LIPTON, REBECCA B. · 1998 to 2007
$3.5M
NCRR NIH HHS M01 RR000055NCRR NIH HHS M01 RR013987NCRR NIH HHS M01-RR13987NCRR NIH HHS UL1 RR024999NCRR NIH HHS UL1-RR024999NIDDK NIH HHS P60 DK020595NIDDK NIH HHS P60-DK20595NIDDK NIH HHS R01 DK044752NIDDK NIH HHS R01-DK44752
6 · The paper itself

Abstract

aimTo explore whether it is possible to predict a child's eventual diabetes phenotype using characteristics at initial presentation, we reassessed 111 young patients on average 7.8 ± 4.2 (2.2-19.7) [mean ± SD (range)] years after diagnosis.

methodsMedical records at diagnosis for 111 patients, aged 0-17, were compared with their follow-up characteristics including stimulated C-peptide (CP) and islet autoantibodies (AB).

resultsInitially, 18 patients were obese; 9 displayed other type 2 diabetes (T2DM) features (polycystic ovary syndrome, acanthosis, diagnosed T2DM); the remaining 84 had a classic type 1 diabetes (T1DM) presentation. At follow-up, 83 patients (75%) with no measured CP were classified as T1DM; 17 (15%) were CP+ and AB- and thus considered T2DM. Eleven patients with both T1DM and T2DM features were classified as having mixed diabetes phenotype (MDM). One-fifth (22 subjects) changed presumed phenotype at follow-up. In multivariable models, T1DM patients were younger at diagnosis, had higher initial glucose values, were more likely to have experienced ketoacidosis, and less likely to be obese or of African American ethnicity. CONCLUSIONS/

interpretationTen percent of subjects had MDM and 15% had T2DM at ∼8 years' duration. Although no onset feature was completely reliable, ketoacidosis and hyperglycemia were more likely to predict T1DM; obesity and African American ethnicity made T2DM more likely. At diagnosis, features of T2DM in addition to obesity were strongly predictive of eventual T2DM phenotype. Given the significant percentage who changed or had mixed phenotype, careful tracking of all young people with diabetes is essential to correctly determine eventual disease type.

Indexed as

AdolescentAdultAutoantibodiesBlack or African AmericanChicagoChildC-PeptideDiabetes MellitusDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2FemaleGlutamate DecarboxylaseHumansInsulin-Secreting CellsLongitudinal StudiesMaleAutoantibodiesC-PeptideGlutamate Decarboxylaseglutamate decarboxylase 2

Identifiers

PMID21426455
PMCPMC3103597
OpenAlexW1992082469

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.